Allarity Therapeutics, Inc. Shares Outstanding (Cover Page)
Allarity Therapeutics, Inc. (ALLR) had Shares Outstanding (Cover Page) of 15.91 million shares as of 2026-08-14, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-14: Entity Common Stock, Shares Outstanding 15.91M shares.
- 2026-05-15: Entity Common Stock, Shares Outstanding 15.91M shares.
- 2026-03-30: Entity Common Stock, Shares Outstanding 15.82M shares.
- 2025-11-13: Entity Common Stock, Shares Outstanding 15.81M shares.
| Period end | Entity Common Stock, Shares Outstanding | Entity Common Stock, Shares Outstanding as first filed |
|---|---|---|
| 2026-08-14 | 15.91M shares 10-Q · filed 2026-08-14 | |
| 2026-05-15 | 15.91M shares 10-Q · filed 2026-05-15 | |
| 2026-03-30 | 15.82M shares 10-K · filed 2026-03-30 | |
| 2025-11-13 | 15.81M shares 10-Q · filed 2025-11-14 | |
| 2025-08-14 | 14.62M shares 10-Q · filed 2025-08-15 | |
| 2025-05-08 | 15.08M shares 10-Q · filed 2025-05-09 | |
| 2025-03-31 | 17.01M shares 10-K · filed 2025-03-31 | |
| 2024-11-13 | 4.43M shares 10-Q · filed 2024-11-14 | |
| 2024-08-05 | 42.38M shares 10-Q · filed 2024-08-05 | |
| 2024-05-13 | 17.61M shares 10-Q · filed 2024-05-14 | |
| 2024-04-26 | 2.39M shares 10-K/A · filed 2024-04-29 | |
| 2024-03-07 | 6.18M shares 10-K · filed 2024-03-08 | |
| 2023-11-08 | 4.56M shares 10-Q · filed 2023-11-14 | |
| 2023-08-10 | 2.73M shares 10-Q · filed 2023-08-14 | |
| 2023-05-11 | 19.14M shares 10-Q · filed 2023-05-11 | |
| 2023-03-08 | 30.00M shares 10-K · filed 2023-03-13 | |
| 2022-11-14 | 10.26M shares 10-Q · filed 2022-11-14 | |
| 2022-10-07 | 10.26M shares 10-Q · filed 2022-10-07 | |
| 2022-05-27 | 9.28M shares 10-Q · filed 2022-05-27 | |
| 2022-05-01 | 8.84M shares 10-K · filed 2022-05-17 | |
| 2021-11-23 | 1.00 shares 10-Q/A · filed 2022-05-17 | 0.00 shares 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |